SeHCAT absorption: a simple test of ileal dysfunction.
A new selenium-labelled synthetic bile salt SeHCAT (taurine conjugate of 23-[75Se]-25-homocholic acid) was assessed as a test of ileal dysfunction in 20 patients with inflammatory bowel disease (IBD). Whole body retention of SeHCAT was compared with tests of vitamin B12 absorption (Schilling test and whole body retention) and the cholylglycine-1-14C breath test and faecal isotope excretion. Clear differentiation, with no overlap was obtained between 10 normal subjects and patients with ileal disease/resection in the SeHCAT 7-day retention results. The Schilling test was more sensitive; enabling discrimination between patients with limited and extensive ileal disease/resection. An unexpected rise in SeHCAT retention was observed in patients with colonic IBD. The 7-day SeHCAT retention is a safe, simple screening test for ileal dysfunction and has practical advantages compared with the Schilling test.
D000328:Adult; D000368:Aged; D003093:Colitis, Ulcerative / Q000175:diagnosis*; D003424:Crohn Disease / Q000175:diagnosis*; D006000:Glycocholic Acid; D006801:Humans; D007077:Ileal Diseases / Q000175:diagnosis* / Q000601:surgery; D008875:Middle Aged; D013656:Taurocholic Acid / Q000031:analogs & derivatives*; D014805:Vitamin B 12; D014915:Whole-Body Counting
D013656:Taurocholic Acid; C033638:23-seleno-25-homotaurocholic acid; D006000:Glycocholic Acid; D014805:Vitamin B 12